Last reviewed · How we verify
Haemostatic solution "Haemoblock" application
Haemoblock is a topical haemostatic agent that promotes blood clotting and wound hemostasis through physical and biochemical mechanisms.
Haemoblock is a topical haemostatic agent that promotes blood clotting and wound hemostasis through physical and biochemical mechanisms. Used for Surgical hemostasis and control of bleeding during surgical procedures, Wound hemostasis in general and specialized surgery.
At a glance
| Generic name | Haemostatic solution "Haemoblock" application |
|---|---|
| Also known as | "Haemoblock" application |
| Sponsor | Ryazan State Medical University |
| Drug class | Topical hemostatic agent |
| Modality | Small molecule |
| Therapeutic area | Hemostasis/Surgery |
| Phase | FDA-approved |
Mechanism of action
Haemoblock functions as a local hemostatic solution applied directly to bleeding surfaces to arrest hemorrhage. It likely works through a combination of mechanisms including physical tamponade, activation of the coagulation cascade, and promotion of platelet aggregation at the wound site. The exact composition and mechanism are proprietary to Ryazan State Medical University.
Approved indications
- Surgical hemostasis and control of bleeding during surgical procedures
- Wound hemostasis in general and specialized surgery
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |